Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Pei

Showing results (831-840 of 864) with videos related to

Pageof 87
Sort By:
Journal of Clinical Immunology|August 12, 2024
The Pathogenic Role of Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Nocardiosis with the Central Nervous System InvolvementYu-Fang Lo, Shang-Yu Wang, Yi-Hui Wu, et al.
Interventional Pain Medicine|September 6, 2024
Real-world outcomes of single-stage spinal cord stimulation in chronic pain patients: A multicentre, European case seriesPasquale De Negri, Jose Francisco Paz-Solis, Philippe Rigoard, et al.
Bone|January 25, 2012
A haplotype of MATN3 is associated with vertebral fracture in Chinese postmenopausal women: Peking Vertebral Fracture (PK-VF) studyJing Zhao, Weibo Xia, Min Nie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 3, 2020
Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-AnalysisMichael Putman, Yu Pei Eugenia Chock, Herman Tam, et al.
Radiology|August 26, 2025
MRI-based Middle Neck Involvement in Stage N1-N2 Nasopharyngeal Carcinoma: A Marker for Risk StratificationGuan-Jie Qin, Wei Jiang, Wu-Qi Zhang, et al.
CA: a Cancer Journal for Clinicians|February 19, 2025
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trialLing-Long Tang, Lin Chen, Gui-Qiong Xu, et al.
Cancer Cell|July 26, 2024
Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON studyJiawei Lv, Ling-Xin Xu, Zhi-Xuan Li, et al.
JAMA|August 23, 2022
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical TrialLing-Long Tang, Rui Guo, Ning Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO GuidelineYu-Pei Chen, Nofisat Ismaila, Melvin L K Chua, et al.
Stem Cell Research & Therapy|May 3, 2022
Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trialLi Zang, Yijun Li, Haojie Hao, et al.
Pageof 87

Showing results (831-840 of 864) with videos related to

Sort By:
Pageof 87
Journal of Clinical Immunology|August 12, 2024
The Pathogenic Role of Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Nocardiosis with the Central Nervous System InvolvementYu-Fang Lo, Shang-Yu Wang, Yi-Hui Wu, et al.
Interventional Pain Medicine|September 6, 2024
Real-world outcomes of single-stage spinal cord stimulation in chronic pain patients: A multicentre, European case seriesPasquale De Negri, Jose Francisco Paz-Solis, Philippe Rigoard, et al.
Bone|January 25, 2012
A haplotype of MATN3 is associated with vertebral fracture in Chinese postmenopausal women: Peking Vertebral Fracture (PK-VF) studyJing Zhao, Weibo Xia, Min Nie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 3, 2020
Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-AnalysisMichael Putman, Yu Pei Eugenia Chock, Herman Tam, et al.
Radiology|August 26, 2025
MRI-based Middle Neck Involvement in Stage N1-N2 Nasopharyngeal Carcinoma: A Marker for Risk StratificationGuan-Jie Qin, Wei Jiang, Wu-Qi Zhang, et al.
CA: a Cancer Journal for Clinicians|February 19, 2025
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trialLing-Long Tang, Lin Chen, Gui-Qiong Xu, et al.
Cancer Cell|July 26, 2024
Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON studyJiawei Lv, Ling-Xin Xu, Zhi-Xuan Li, et al.
JAMA|August 23, 2022
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical TrialLing-Long Tang, Rui Guo, Ning Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO GuidelineYu-Pei Chen, Nofisat Ismaila, Melvin L K Chua, et al.
Stem Cell Research & Therapy|May 3, 2022
Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trialLi Zang, Yijun Li, Haojie Hao, et al.
Pageof 87